Dr. Michael Keating: My Hopes for the Future of CLL Treatment Recorded on December 8, 2014
|
|
- Adela O’Neal’
- 6 years ago
- Views:
Transcription
1 Patient Power Knowledge. Confidence. Hope. Dr. Michael Keating: My Hopes for the Future of CLL Treatment Recorded on December 8, 2014 Michael Keating, MB, BS Professor of Medicine, Department of Leukemia MD Anderson Cancer Center Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That s how you ll get care that s most appropriate for you. Welcome to Patient Power. I'm Andrew Schorr, and we're in San Francisco at the American Society of Hematology meeting. It gives us a chance to get together with old friends and in some cases providers, in my case, one in particular, who I believe has saved and lengthened my life. As some people know, in 1996 I was diagnosed with chronic lymphocytic leukemia, CLL. And by connecting with other patients, those other patients said, you know, you need to go from your home city and maybe go to another city where they specialize in what you've got and see a doctor who is a specialist in that. I went to Houston, Texas. I went to MD Anderson Cancer Center, and I want you to see who I met 18 years ago, and that's Dr. Michael Keating. Michael. Andrew. Pleasure to see you. Great to be here. And so I want to reminisce with you a little bit. We have an 18-year history, and things are changing for you, and we have sort of a wide, long view. When I saw you in 1996, I was worried that I'd be dead, you know, because I didn't know the difference between chronic leukemias and acute leukemias. There was a man in Seattle, very prominent, who died of an acute leukemia. I thought that was me. And my community oncologist, well-meaning at that time, was saying, you need fludarabine (Fludara ) and cyclophosphamide (Cytoxan ) right now. And you looked at all the bone marrow results, and you said no. And you said, I think I'll have something better, and you don't need treatment right away. And if you do, we may have a trial. And my wife said to you, I don't know if you remember this, said, Dr. Keating, we had thought about having a third child, but we don't know Andrew's future. And you gave her a hug, as you do with so many people, and you said, go have your baby. Which I still say, folks, we should have named the kid Michael. We didn't. Okay. All right. So we've come a long way, and at the time when I interviewed you, too, for other patients you said, well, I'm not going to retire, I'm trying not to retire until CLL is cured.
2 Yes. Okay. We've come a long way. As you look back over the progress and younger doctors coming along, how do you feel about things? It's time for the knock-out punch, because I think we've already got to the point where in the study that you were on which started about 16 years ago we still have a third of the patients that have never relapsed getting out to 11 to 16 years. I've never had any more treatment for it. So that and we can't find any leukemia in the vast majority of those patients, so it's a functional cure. The patients are well. They've been off treatment for 12, 13, 14, 15, years, etc., and they have never needed to have anything else. And we've got a pretty good idea as to which group of patients they happen to be. Right. This was FCR. Yes. And the FCR has been approved as the standard for younger, fit patients, and I've now certainly got to the stage where I'm no longer younger and no longer as fit as I once was. But there's a changing of the whole mentality. I think that the FCR leveraged us into the point where we said a number of patients are probably cured at the present time with FCR. And we now know that we can get away with starting patients off on different treatments that's not chemotherapy and not do them any harm. And, fortunately, we have a number of very, very active drugs at the present time that have come along that are oral. They're well tolerated. Patients can be treated up into their 90s with them, and they begin to feel well in a very short period of time. It doesn't damage the normal things that chemotherapy does. So I said that I oh, about four years and three or four months ago that I needed five years, and I think by the end of August all of the cure strategies will be put in place. And we just need the young people to watch what happens and cheer the success of them. Now, you've been very devoted. You have a foundation, CLL Global, and you've really tried to make this a worldwide effort in bringing doctors together in collaboration, and that probably when you started in your career doctors didn't, researchers didn't collaborate so much. But now there seems to be a sharing of information, a true community working together, the patients, too, and that must be satisfying to you. It's very satisfying, and one of the gifts was that I was fired from acute leukemia and I had to find something to do so that I went to the CLL, because nothing much was happening. Fludarabine was the start of the change. And the thing that was totally unique about the CLL community was that they were truly collegial. They celebrated every success that any one of them had, because there were very few successes at that time. And by and large that attitude has been maintained in CLL ever since. And I think part of it is due to the leadership of Professor Jacques-Louis Binet in Europe and Canty Rye in the United States, who really established this whole sense of we can do more together than we can by ourselves. And it was a change, because the acute leukemia area was very, very competitive. Everyone wanted to be number one, and it was just not as nice.
3 The wonderful thing about dealing with CLL is that you really do get to know your patients as people. So, you know, I tell the story many times about how your wife said, what about going for number three, and I thought that's what life is all about. And it can't be measured by longevity totally, and so we just have to get to know what people want. I should mention that your daughter is in hematology/oncology, so it's a family affair. So it's been the Keatings have been very devoted to us patients, and we've developed these relationships. So there's discussion now is can we get to a cure, you were mentioning that, and exciting medicines to keep CLL truly chronic and live better. But do you think we'll get to the point where maybe with some combination medicines or something next where someone, like I was able to do with FCR but for other people on oral therapies, where not only do we knock the disease down but we knock it out? I think it's very, very likely. I think in the vast, vast majority of patients now even with some of the single agents, the new agents, we can get to the point where there's just a small amount of disease left behind so that there are a number of prospects after that. There are other drugs that come along that we are a little nervous about using them when there's a lot of disease, but they're tailor-made for the situation where there's a very small amount of tumor left behind. And these were the Bcl-2 inhibitors that the ABT-199 and now they've given it a name, which I can't remember yet, and but the combination of ibrutinib and agents like this are already in the planning phase. And I think that it is really getting to the point where the majority of patients after a period of 12 months we will not be able to find any sign of the disease. Now, I remember years ago when I was first starting the FCR trial, and I can't remember the patient's name, but he I saw him while I was going through treatment, and he was a sick guy. And he had probably much more aggressive CLL, and he passed on. And, unfortunately, we all know that's happened, and there have been versions of CLL that have just been harder electro treat. Yes. So while we talk about progress for so many people, for those people with certain mutations where what do we have for them now to help them really do better and have the same hope that many others have had? The major problem child is people that have lost part of chromosome 17 as detected on the FISH test, or have a mutation in the gene that's associated with that, namely p53, and those patients have not done well on chemotherapy. Chemotherapy just doesn't work very well, and it's not very well tolerated. But now we have ibrutinib (Imbruvica) and idelalisib (Zydelig) and AB-T199 that are all effective in that disease. But as we get more experienced with it, we find that a certain number of patients after about 12 months will develop transformations and/or aggressive lymphoma, or they will just have a difficulty in tolerating the drugs. But with 12 months we can get to the point where they can be candidates for allogeneic stem cell transplants, the mini transplants which are potentially curative. The chimeric antigen receptor educated T cells have the potential to eradicate not only the residual disease in the 17p group of patients but generally, and so that we have brought the point where the patients are feeling better, their counts are better, their organ function's better, and they will tolerate these transplants better until we don't need transplants anymore. Now, looking to the future there's a lot of buzz. There's a lot of research starting now at the MD Anderson too related to the sort of burgeoning field of immuno-oncology. Now, CAR T-cell therapy is part of that but not only. We've heard terms like PD-1 and PDL-1, and it's been applying in solid tumors but applying here, too. Where as I understand it where your
4 immune system can sort of wake up and it can see the cancer cells and do the job that it didn't do when you developed cancer first. Are you excited about that? Extremely excited. The transformation that has come about with just single antibody therapy in melanoma and lung and kidney cancer, etc., are truly spectacular so that we've got from a, in a subset of high-risk patients, from 3 percent five-year disease-free to 20 percent. And when you put two of these agents together, it gets up to about 35 percent, and that really is something that we've never seen before. And at this meeting, there have been a couple of presentations in Hodgkin's disease where just using one of these checkpoint inhibitor antibodies the vast majority of patients are responding with advanced disease and getting complete remissions. And to let you know how we sort of envision this, it's the cancer cell, whether it be CLL, leukemia, lymphoma or Hodgkin's solid tumors, is sitting there, and there are chemicals on the surface that trap the immune cells. So the immune cell's in this death hug so that they can't do anything. But this wakes them up, breaks them apart so that the immune system has been trying to kill the cancer cell but hasn't been able to get the job done. We know that CLL is a very good target for immunotherapy, because it can be cured quite consistently with substantial risk by using allogeneic stem cell transplant where you put in a new immune system. Now I think that we have the right target. We have the right group of chemicals to look at. There's another drug which is obinuntuzumab (Gazyva ), which has just been approved for acute lymphocytic leukemia. And that's got a molecule on one end which will attach to the ALL cells but also the CLL cells and another molecule at the other end that attaches to the immune T cells, so that the success in ALL I'm sure will be translated into the same sort of success. So it's not a question of are we going to cure CLL and leave the patient with no disease? The question is what percentage of the patients will be cured? And I predict that in five years time probably about 80 to 90 percent of the patients will be free of detectable leukemia. Wow. Okay. Well, my mother-in-law would always say, from your lips to God's ear. He listens. We just don't talk to him very much sometimes. So, Michael, just a couple of other things, just to be clear for people. You've given up a lot of the administrative stuff you've been involved in. You're still seeing patients. Are you going to keep on for a while? Yes. I've cut back to four clinic days a week, because I want to have I still see the same number of patients during the week. They're just crowded in a little more. But I want to have Friday as thinking day. Good for you. And I want to spend more time developing the next generation of CLL physicians, because they'll be using technology that wasn't even imagined when I was going through medical school. Medical school in Australia was that's when they were developing the code for DNA and look how far things have come in that period of time in one career. I want to think back with you for a second. So when you started your career with leukemias, unfortunately a lot of people passed on.
5 Almost all. And now I'm here and many others we can think about, and you see us living well. How are you feeling about that? I feel some happiness, but I still am angry that we're not doing better, and the fire still has to keep burning. And I hope that what's happening in medicine these days doesn't quench the fire on people, because we have to let them run as fast as they can and get the obstacles out of the way. Because there's a ton of talent, there's a ton of technology, there's a ton of creativity, and we just need to harness it, because it's one of the things that doctors do best. They chase the enemy, and they like to kill it. One of the areas that I think is very gratifying is that patients are living well, but they always have at the back of their mind they're not quite normal. And we have the likelihood of getting a number of skin cancers and other cancers, etc. So now that people are living longer we don't say, okay, getting rid of the leukemia is the only thing that we want to achieve. We need to see if we can normalize their immune system, detect emerging second cancers early so that we can stop them from limiting their life, and just just give them everything that we can. Well, you've been instrumental in so much of this, Michael, and you know from me and from Esther and from that kid who is on earth, Aton, who wouldn't have been here had you not given us the confidence to go forward, I want to thank you from the bottom of my heart. But not just me. Someone else who works with us, Carol Preston, is another one of your patients. Carol has been living with CLL, and so we want to stay here, Carol. Stay here. Have a seat, Carol. Maybe you can just scooch down for a second. I want you to just come between us. So this is what it's about, right, Michael? It is. Because Carol, when she first came down, she's a very intense lady. She has high levels of expectation. But it's been wonderful to see the sense of serenity increase. The longer she's in remission, the better she feels, looking forward to doing new things in her life. It's just wonderful. And devoted to patients, with us with Patient Power. Carol Preston: And since I first saw you I've probably traveled to 12 or 14 countries, so I haven't I have itchy feet. Well, there are many more countries, so... Michael, thank you. I'm going to give him a hug on camera here, folks. This is what we do with this guy. Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That s how you ll get care that s most appropriate for you.
Section 4 Decision-making
Decision-making : Decision-making Summary Conversations about treatments Participants were asked to describe the conversation that they had with the clinician about treatment at diagnosis. The most common
More informationDr. Gopal, are you encouraged in the direction of where research is headed and its benefit for patients?
Targeting the Tumor in Lymphoma July 8, 2009 Ajay Gopal Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff or Patient
More informationFine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013
Fine-Tuning Immunotherapy to Treat Prostate Cancer Recorded on: April 24, 2013 John Corman, M.D. Medical Director, Floyd & Delores Jones Cancer Institute at Virginia Mason Virginia Mason Medical Center
More informationBenefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm. Introduction
Benefits of Survivorship Treatment Care Plans Webcast May 13, 2009 Scott Baker, M.D., M.S. Donald Wilhelm Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
More informationNews from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O.
News from ASH: Updates on Lymphoma and Other Blood Cancers ASH Conference Coverage December 8, 2008 Andrew Evens, D.O. Please remember the opinions expressed on Patient Power are not necessarily the views
More informationThe Latest in Non-Hodgkin Lymphoma News From ASCO
Patient Power Knowledge. Confidence. Hope. The Latest in Non-Hodgkin Lymphoma News From ASCO John Leonard, MD Associate Dean for Clinical Research Weill Cornell Medical College Please remember the opinions
More informationMinimally Invasive Surgery Offers Promise for Pancreatic Cancer Patients
Minimally Invasive Surgery Offers Promise for Pancreatic Cancer Patients Recorded on: August 1, 2012 Venu Pillarisetty, M.D. Surgical Oncologist Seattle Cancer Care Alliance Please remember the opinions
More informationAiming for a CLL Treatment Home Run Recorded on June 1, 2014
Patient Power Knowledge. Confidence. Hope. Aiming for a CLL Treatment Home Run Recorded on June 1, 2014 Thomas Kipps, MD, PhD Deputy Director of Research Operations UC San Diego Moores Cancer Center Please
More informationHello and welcome to Patient Power sponsored by Northwestern Memorial Hospital. I'm Andrew Schorr.
Brain Tumor Clinical Trials Webcast November 22, 2011 Sean Grimm, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern Memorial Hospital, its medical
More informationAdvances in Pediatric Bone Marrow Transplant Webcast March 4, 2011 Scott Baker, M.D., M.S. Anna Robinson. Introduction
Advances in Pediatric Bone Marrow Transplant Webcast March 4, 2011 Scott Baker, M.D., M.S. Anna Robinson Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
More informationTracking Genetic-Based Treatment Options for Inflammatory Bowel Disease
Tracking Genetic-Based Treatment Options for Inflammatory Bowel Disease Recorded on: June 25, 2013 Melvin Heyman, M.D. Chief of Pediatric Gastroenterology UCSF Medical Center Please remember the opinions
More informationBreast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Introduction
Breast Cancer Imaging Webcast October 21, 2009 Peter Eby, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff or
More informationPROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO
PROSTATE CANCER SCREENING SHARED DECISION MAKING VIDEO 1 00:00:00,067 --> 00:00:10,968 2 00:00:10,968 --> 00:00:12,701 So, you were given a decision aid sheet 3 00:00:12,701 --> 00:00:14,567 about prostate
More informationLiving With Myeloma Webcast April 7, 2010 Tanya Wahl, M.D. Steve Henkel. Steve s Story
Living With Myeloma Webcast April 7, 2010 Tanya Wahl, M.D. Steve Henkel Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, partners or Patient Power.
More informationMarty: I had my physical in 2006, and my physician said that I had myelofibrosis and said I had three to five years to live.
Advances in the Treatment of Myeloproliferative Disorders Webcast April 28, 2009 Srdan Verstovsek, M.D., Ph.D. Marty Prager Please remember the opinions expressed on Patient Power are not necessarily the
More informationSection 4 Decision-making
Decision-making : Experience of health professional communication Conversations about s Participants were asked to describe the conversations they have had about mitochondrial disease options. The most
More informationDiabetes Remission with Weight Loss - Frankly Speaking EP 49
Diabetes Remission with Weight Loss - Frankly Speaking EP 49 Transcript Details This is a transcript of an episode from the podcast series Frankly Speaking accessible at Pri- Med.com. Additional media
More informationHello and welcome to Patient Power sponsored by UCSF Medical Center. I m Andrew Schorr.
The Integrated Approach to Treating Cancer Symptoms Webcast March 1, 2012 Michael Rabow, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationBreakthrough Understanding in Pancreatic Cancer Therapy
Breakthrough Understanding in Pancreatic Cancer Therapy Recorded on: May 28, 2013 Sunil R. Hingorani, M.D., Ph.D. Associate Member Fred Hutchinson Cancer Research Center Please remember the opinions expressed
More informationConversations: Let s Talk About Bladder Cancer
Understanding Biomarkers Matt Gaslky, MD, Professor of Medicine Icahn School of Medicine at Mount Sinai Piyush Agarwal, MD, Head, Bladder Cancer Section Urological Oncology Branch, National Cancer Institute
More informationHello and welcome to Patient Power sponsored by the Seattle Cancer Care Alliance. I'm Andrew Schorr.
New Hope For Melanoma Webcast April 6, 2011 Kim Margolin, M.D. David Byrd, M.D. Kathy Sparks Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care
More informationAndrew Schorr: Dr. Young, for patients receiving initial treatment could you discuss the findings comparing horse ATG and rabbit ATG?
What s New in Aplastic Anemia Treatment American Society of Hematology Meeting December 2011 Dr. Neal S. Young Please remember the opinions expressed on Patient Power are not necessarily the views of our
More informationThe Current Research on Stretching and Flexibility is Flawed!
Transcript from: https://www.youtube.com/watch?v=qz0ot7tbbg0 Original Article: http://stretchcoach.com/articles/proper-stretching/ The Current Research on Stretching and Flexibility is Flawed! Hi. I'm
More informationOne of the areas where it's certainly made it difference is with the transplantation of the liver. Dr. Roberts thinks so much for joining us.
Benefits and Risks of Living Donor Liver Transplant Webcast May 28, 2008 John Roberts, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationNon Muscle Invasive Bladder Cancer (NMIBC) Experts Discuss Treatment Options. Part II: The Future Treatment of NMIBC
Non Muscle Invasive Bladder Cancer (NMIBC) Experts Discuss Treatment Options Wednesday, June 14, 2017 Part II: The Future Treatment of NMIBC Presented by Dr. Arlene Siefer-Radtke is an Associate Professor
More informationCognitive Challenges After Hormone Therapy August 26, 2009 Webcast Monique Cherrier, Ph.D. Celestia Higano, M.D. Introduction
Cognitive Challenges After Hormone Therapy August 26, 2009 Webcast Monique Cherrier, Ph.D. Celestia Higano, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of
More informationThe Parent's Perspectives on Autism Spectrum Disorder
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/autism-spectrum/the-parents-perspectives-on-autism-spectrumdisorder/6809/
More informationEpisode 93: What Role Stem Cells in Leukaemia?
Published on Up Close (https://upclose.unimelb.edu.au) Episode 93: What Role Stem Cells in Leukaemia? What Role Stem Cells in Leukaemia? VOICEOVER Welcome to Up Close, the research, opinion and analysis
More informationSurgical Treatment For Prostate Cancer Webcast May 6, 2010 John W. Davis, M.D., F.A.C.S. Mike Whyte. Mike s Story
Surgical Treatment For Prostate Cancer Webcast May 6, 2010 John W. Davis, M.D., F.A.C.S. Mike Whyte Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson
More informationSurgical Options for Breast Cancer October 28, 2009 Kristine Calhoun, M.D. Suzie Hagerland. Introduction
Surgical Options for Breast Cancer October 28, 2009 Kristine Calhoun, M.D. Suzie Hagerland Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance,
More informationTargeted Therapies in Breast Cancer Webcast October 24, 2007 Julie Gralow, M.D. Hosted By Andrew Schorr
Targeted Therapies in Breast Cancer Webcast October 24, 2007 Julie Gralow, M.D. Hosted By Andrew Schorr Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle
More informationHow a CML Patient and Doctor Work Together
How a CML Patient and Doctor Work Together Recorded on: November 5, 2012 Jessica Altman, M.D. Assistant Professor, Department of Medicine, Hematology Oncology Division Feinberg School of Medicine, Northwestern
More informationKeeping Hope Alive: Alternative Options for Bone Marrow Transplant Webcast February 9, 2011 Paul O'Donnell, M.D., Ph.D. Ronni Maestas Jessie Quinn
Keeping Hope Alive: Alternative Options for Bone Marrow Transplant Webcast February 9, 2011 Paul O'Donnell, M.D., Ph.D. Ronni Maestas Jessie Quinn Please remember the opinions expressed on Patient Power
More informationClinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer
Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Questions Answered by Andrea Apolo, MD is a Lasker Clinical Research Scholar and tenure-track
More informationProgress and Promises of Leukemia Therapy Webcast December 14, 2010 Olga Frankfurt, M.D. Christy Moore. Introduction
Progress and Promises of Leukemia Therapy Webcast December 14, 2010 Olga Frankfurt, M.D. Christy Moore Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern
More informationCharlie: I was just diagnosed with CLL, so my doctor and I are now in the process of deciding what
Track 3: Goals of therapy Charlie: I was just diagnosed with CLL, so my doctor and I are now in the process of deciding what treatment I ll have. My doctor told me there are several factors she will use
More informationAndrew Schorr: And you're a retired businessman. Tell us about this diagnosis. What was going on for you that suddenly you were sick? What happened?
Advances in the Treatment of Stomach Cancer Webcast August 5, 2008 Linus Ho, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson Cancer Center,
More informationBreakthroughs in Lymphoma and Other Blood Cancers Health Radio Network December 17, 2006 Andrew Evens, D.O. Introduction
Breakthroughs in Lymphoma and Other Blood Cancers Health Radio Network December 17, 2006 Andrew Evens, D.O. Please remember the opinions expressed on Patient Power are not necessarily the views of Health
More informationChronic Lymphocytic Leukemia (CLL): Advances in Research and Treatment Health Radio April 16, 2007 Michael Keating, M.B., B.S.
Chronic Lymphocytic Leukemia (CLL): Advances in Research and Treatment Health Radio April 16, 2007 Michael Keating, M.B., B.S. Please remember the opinions expressed on Patient Power are not necessarily
More informationHow to Foster Post-Traumatic Growth
How to Foster Post-Traumatic Growth Module 3 - Transcript - pg. 1 How to Foster Post-Traumatic Growth The Critical Role of Connection in Post-Traumatic Growth with Sue Johnson, EdD; Kelly McGonigal, PhD;
More informationBBC Learning English 6 Minute English 2 October 2014 Sleeping on the job
BBC Learning English 6 Minute English 2 October 2014 Sleeping on the job NB: This is not a word for word transcript Hello I'm. Welcome to 6 Minute English. I'm joined today by. Hello..? Hello? Oh sorry,
More informationIntroduction. All Rights Reserved
Sarcoma: Patients and Doctors Working Together to Fight a Rare Cancer Health Radio Network February 4, 2007 Chappie Conrad III, M.D., F.A.C.S. Douglas Hawkins, M.D. Jared Holmes Please remember the opinions
More informationCourtesy of RosenfeldInjuryLawyers.com (888)
CROSS-EXAMINATION BY MR. BERGER: Q DR. WATFORD, WE HAVE MET TWICE BEFORE. DO YOU RECALL THAT? Q ONCE IN YOUR IN DECEMBER, AND YOU WERE KIND ENOUGH TO MEET WITH US? Q ONCE IN JANUARY WHEN WE BROUGHT YOU
More informationHello and welcome to Patient Power sponsored by UW Medicine Health System. I'm Andrew Schorr
Advanced Techniques for Treating Liver Tumors Webcast James O. Park, M.D. Veena Shankaran, M.D. Raymond S.W. Yeung, M.D., FRCS(C), FACS Derek Epps November 28, 2011 Please remember the opinions expressed
More informationWhat s the Latest in Prostate Cancer Immunotherapy Options?
What s the Latest in Prostate Cancer Immunotherapy Options? Jeri Kim, MD Associate Professor, Department of Geritourinary Medical Oncology The University of Texas MD Anderson Cancer Center Sumit K. Subudhi,
More informationHow to Foster Post-Traumatic Growth
How to Foster Post-Traumatic Growth Module 7, Part 2 - Transcript - pg. 1 How to Foster Post-Traumatic Growth Two Ways to Ignite Accelerated Growth Part 2: How Your Choice of Language Can Transform an
More informationComparing Liquid-Based Cytology Methods in the Detection of Cervical Cancer: Perspectives from Dr. Daniel Ferrante
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/advances-in-womens-health/comparing-liquid-based-cytology-methodsdetection-cervical-cancer-perspectives-dr-daniel-ferrante/7592/
More informationHello and welcome to Patient Power sponsored by UCSF Medical Center. I'm Andrew Schorr.
Managing Pain from Shingles Webcast August 22, 2011 George Pasvankas, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff
More informationRobotic Surgery: A Better Option for Many Head & Neck Cancers
Robotic Surgery: A Better Option for Many Head & Neck Cancers Neal Futran, MD, DMD Director of Head and Neck Surgery, Department of Otolaryngology UW Medicine Eduardo Mendez, MD Assistant Professor, Otolaryngology:
More informationASCO 2016: Ask the Lung Cancer Experts
Live @ ASCO 2016: Ask the Lung Cancer Experts Charu Aggarwal, MD, MPH Assistant Professor of Medicine University of Pennsylvania Health System Liza Villaruz, MD Hematology/Oncology Specialist University
More informationA CLL Expert Roundtable: Treatment News From ASH 2018
Patient Power Knowledge. Confidence. Hope. A CLL Expert Roundtable: Treatment News From ASH 2018 Nitin Jain, MD Assistant Professor, Department of Leukemia, Division of Cancer Medicine The University of
More informationChemotherapy Resistance: The Fault in Our Cells
Chemotherapy Resistance: The Fault in Our Cells [MUSIC PLAYING] JOHN F. KENNEDY: We choose to go to the moon. We choose to go to the moon in this decade and do the other things, not because they are easy,
More informationAndrew Schorr: Okay. Let's go back to just a little more than a year ago. How were you doing? What was life like?
Transcatheter Aortic Valve Implantation Webcast February 22, 2011 Charles Davidson, M.D. Rose Spagnola Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern
More informationAdele Wolfson Interview, February J: June A: Adele :30
Adele Wolfson Interview, February 2016 J: June A: Adele :30 A: Hello. I'm here. J: Hi, Adele. I'm so sorry to keep you waiting for so long. A: That's alright I had a delightful discussion with Dawn. We
More informationCancer in Young Adults Health Radio July 11, 2007 Brandon Hayes-Lattin,M.D. Todd Smaka, M.D. Introduction
Cancer in Young Adults Health Radio July 11, 2007 Brandon Hayes-Lattin,M.D. Todd Smaka, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Health Radio, our sponsors,
More informationSurgical Treatment For Pancreatic Cancer Webcast March 22, 2011 Venu Pillarisetty, M.D. Stan Barer. Introduction
Surgical Treatment For Pancreatic Cancer Webcast March 22, 2011 Venu Pillarisetty, M.D. Stan Barer Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer
More informationMS Learn Online Feature Presentation MS and Your Emotions, part two Deborah Miller, PhD. Tracey>> Welcome to MS Learn Online, I m Tracey Kimball.
Page 1 MS Learn Online Feature Presentation MS and Your Emotions, part two Deborah Miller, PhD Tracey>> Welcome to MS Learn Online, I m Tracey Kimball. Tom>> and I m Tom Kimball. In the first installment
More informationBrachytherapy for Prostate Cancer Webcast November 4, 2008 David Swanson, M.D. Steven Frank, M.D. Introduction
Brachytherapy for Prostate Cancer Webcast November 4, 2008 David Swanson, M.D. Steven Frank, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson
More informationPlease Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222.
Announcer: Please Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222. Welcome to Stay Happily Married, your source for weekly updates on the latest tips and
More informationCarrier Screening in your Practice Is it Time to Expand your View?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/carrier-screening-your-practice-it-time-expandyour-view/9648/
More informationYou re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team.
Transcript of learning module Shared decision making (Dur: 26' 13") Contributors: Anna Sayburn and Alf Collins Available online at: http://learning.bmj.com/ V/O: You re listening to an audio module from
More informationAn Update on BioMarin Clinical Research and Studies in the PKU Community
An Update on BioMarin Clinical Research and Studies in the PKU Community Barbara Burton, MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Director of PKU Clinic, Children
More informationMS Learn Online Feature Presentation Stress and MS: What We Know Featuring Fred Foley, Ph.D.
Page 1 MS Learn Online Feature Presentation Stress and MS: What We Know Featuring Fred Foley, Ph.D. >>Kate Milliken: Hello. I'm Kate Milliken and welcome to MS Learn Online. Aside from the stress that
More informationLet me introduce you to her. That s Barbara Scribner who joins us from Kent, Washington. Barbara, thank you so much for joining us.
Lung Cancer: Detection and Early Intervention Webcast November 30, 2009 Douglas E. Wood, M.D. Jason Chien, M.D., M.S. Barbara Scribner Please remember the opinions expressed on Patient Power are not necessarily
More informationConnecting With the Virtual CLL Community
Connecting With the Virtual CLL Community Lisa Minkove CLL Patient and Advocate Andrew Schorr CLL Patient and Patient Power Co-Founder Stella and Len Care Partner and CLL Patient Patrick CLL Patient Please
More informationAfter Soft Tissue Sarcoma Treatment
After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?
More informationHIV Housing Care Continuum Webinar 1 August 3, 2016
Page 1 HIV Housing Care Continuum August 3, 2016 Rita Flegel: Hello and welcome. I'm Rita Flegel, the Director of HUD's Office of HIV/AIDS Housing. And presenting with me today is Amy Palilonis also from
More informationHereditary Cancer Syndromes and the Obstetrician/Gynecologist
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/hereditary-cancer-syndromes-and-theobstetriciangynecologist/6990/
More informationHow to Work with the Patterns That Sustain Depression
How to Work with the Patterns That Sustain Depression Module 5.2 - Transcript - pg. 1 How to Work with the Patterns That Sustain Depression How the Grieving Mind Fights Depression with Marsha Linehan,
More informationOvercoming Seasonal Affective Disorder Webcast December 19, 2011 Pamela Sheffield, M.D. Crystal Wong, M.D.
Overcoming Seasonal Affective Disorder Webcast December 19, 2011 Pamela Sheffield, M.D. Crystal Wong, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UW Medicine,
More informationAndrew Schorr: Hello and welcome once again to Patient Power, sponsored by the Seattle Cancer Care Alliance. I'm Andrew Schorr.
The Latest in Gynecological Cancers Webcast May 21, 2008 Banjamin Greer, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its
More informationDUNG NGUYEN - October 28, 2013 Recross-Examination by Ms. Gutierrez. MS. LOGAN: Thank you, Judge. KATHLEEN MCKINNEY,
DUNG NGUYEN - October, Recross-Examination by Ms. Gutierrez 0 MS. LOGAN: Thank you, Judge. KATHLEEN MCKINNEY, having been first duly sworn, testified as follows: DIRECT EXAMINATION BY MS. LOGAN: Q. Good
More informationAbhinav: So, Ephraim, tell us a little bit about your journey until this point and how you came to be an infectious disease doctor.
Announcer: Welcome to the Science is the Best Medicine podcast with your host Dr. Abhinav Sharma, exploring the pressing scientific and healthcare issues of our time. Dr. Abhinav Sharma: Superbugs we hear
More informationScript and Context. RN: Thanks, Ms. Deal. May I check your name bracelet? I just want to make sure the information is correct.
Client appearance: Slouching in chair Hair unkempt Disheveled clothing Withdrawn Avoids eye contact initially Script and Context RN- adjunct clinical faculty SP- standardized patient (trained professional
More informationHow to Foster Post-Traumatic Growth
How to Foster Post-Traumatic Growth Bonus 3, Part 2 - Transcript - pg. 1 How to Foster Post-Traumatic Growth How to Help Clients Complete the Journey From Trauma to Post-Traumatic Growth Part 2: 3 Core
More informationAndrew Schorr: What treatment have you had, Gaye, then in that interim four years? What's happened?
Navigating Sarcoma Treatments Health Radio June 20, 2007 Christopher Ryan, M.D. Kevin Norwood, M.D. Angela Lim, LICSW, OSW-C Gaye Johnson Please remember the opinions expressed on Patient Power are not
More informationImmuno-Oncology: Perspectives on Current Therapies & Future Developments
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/immuno-oncology-perspectives-currenttherapies-future-developments/9502/
More informationCase Study: Biomedical Scientist - Caroline
Case Study: Biomedical Scientist - Caroline What do you do? I'm a biomedical scientist, in haematology. I work in an NHS hospital. We study the morphology of the cells - what they actually look like, such
More informationPatient Selection and Sequencing of Therapies in the New Melanoma Landscape
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationHow to Foster Post-Traumatic Growth
How to Foster Post-Traumatic Growth Module 9 - Transcript - pg. 1 How to Foster Post-Traumatic Growth Are Some Clients Predisposed for Post-Traumatic Growth? with Christine Padesky, PhD; Ron Siegel, PsyD;
More informationWhy Is Mommy Like She Is?
Why Is Mommy Like She Is? A Book For Kids About PTSD Deployment Edition Patience H. C. Mason Patience Press High Springs, Florida PP Patience Press 2010 by Patience Mason All rights reserved. No part of
More informationVIDEO_ Sarah Hallberg - Interview (San Diego 2017)
VIDEO_ Sarah Hallberg - Interview (San Diego 2017) Dr. Andreas Eenfeldt: If you are a doctor and you want to help your patients with type 2 diabetes to reverse their disease, how do you do it? You can
More informationProton Therapy and Pediatric Cancer Webcast June 8, 2010 Anita Mahajan, M.D. Denise Rager. Introduction
Proton Therapy and Pediatric Cancer Webcast June 8, 2010 Anita Mahajan, M.D. Denise Rager Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson Cancer
More informationColon Cancer Screening Webcast April 23, 2008 William Grady, M.D. Introduction
Colon Cancer Screening Webcast April 23, 2008 William Grady, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Seattle Cancer Care Alliance, its medical staff
More informationAfter Adrenal Cancer Treatment
After Adrenal Cancer Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. Lifestyle Changes After Treatment for Adrenal Cancer
More informationGenetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.
Hi, I m Kaylene Ready, a genetic counselor who specializes in the education and counseling of individuals at high-risk for hereditary breast and ovarian cancer syndrome. Women with an inherited BRCA 1
More informationsuicide Part of the Plainer Language Series
Part of the Plainer Language Series www.heretohelp.bc.ca What is? Suicide means ending your own life. It is sometimes a way for people to escape pain or suffering. When someone ends their own life, we
More informationAs a Lung Cancer Patient, What Information Do I Need to Make the Best Choices?
As a Lung Cancer Patient, What Information Do I Need to Make the Best Choices? Mary Ellen Hand, RN, BSN Nurse Coordinator Rush University Medical Center Emma Shtivelman, PhD Chief Scientist Cancer Commons
More informationNext Level Practitioner
Next Level Practitioner - Fear Week 115, Day 4 - Dan Siegel, MD - Transcript - pg. 1 Next Level Practitioner Week 115: Fear in the Brain and Body Day 4: How to Work with Fear That Feels Irrational with
More informationSECOND TRADITION SKIT
SECOND TRADITION SKIT NARRATOR Welcome to the presentation of our skit on Al Anon's Second Tradition. I am Dolly Delegate and I'd like to introduce you to our cast. DOLLY DELEGATE AUDREY AUTHORITY BOSSY
More information#032: HOW TO SAY YOU'RE SICK IN ENGLISH
#032: HOW TO SAY YOU'RE SICK IN ENGLISH Hi, everyone! I'm Georgiana, founder of SpeakEnglishPodcast.com. My mission is to help YOU to speak English fluently and confidently. In today's episode: I'll talk
More informationCA: Hi, my name is Camille, and I will be interviewing you today. Would you please introduce yourself?
Interviewee: Ying Li Interviewer: Camille Alvarado Date of Interview: April 17, 2007 Location: Worcester, Massachusetts Transcriber: Randylin Bourassa, The Salter School Interpreters: Nicole Heart and
More informationExpert Tips to Stop Smoking Now Webcast January 17, 2011 Vicky Fang, M.D. Yunyu Cao, M.D. Introduction
Expert Tips to Stop Smoking Now Webcast January 17, 2011 Vicky Fang, M.D. Yunyu Cao, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UW Medicine, their staff,
More informationRoles of Non-HDL Cholesterol in Risk Assessment and Treatment
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/roles-of-non-hdl-cholesterol-in-risk-assessment-andtreatment/7066/
More informationShoulder Arthritis and Shoulder Replacement Surgery Webcast June 22, 2010 Matthew Saltzman, M.D. Introduction
Shoulder Arthritis and Shoulder Replacement Surgery Webcast June 22, 2010 Matthew Saltzman, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of Northwestern Memorial
More informationNeo-adjuvant Therapy and Dynamic Imaging for Breast Cancer Webcast November 12, 2008 Jennifer Specht, M.D. Janelle Sabol
Neo-adjuvant Therapy and Dynamic Imaging for Breast Cancer Webcast November 12, 2008 Jennifer Specht, M.D. Janelle Sabol Please remember the opinions expressed on Patient Power are not necessarily the
More informationDr. Hwu, welcome to Patient Power. First of all, do we have any clue why this cancer is rising faster than any other?
Advances in the Treatment of Melanoma Webcast May 20, 2008 Patrick Hwu, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of M. D. Anderson Cancer Center, its medical
More informationMark Hyman, M.D. Transcript
Mark Hyman, M.D. Transcript Mark Hyman, M.D.: I've been seeing chronically ill patients for 20 years, and there are certain patients who are resistant to getting better using functional medicine, and when
More informationNext Level Practitioner
Next Level Practitioner - Best Advice Week 88, Day 3 - Ed Tronick, PhD - Transcript - pg. 1 Next Level Practitioner Week 88: Treatment Specific Advice Day 3: How Advice Can Change Our Outlook on Our Therapeutic
More informationWhy Are So Many Clinicians Choosing to Practice Functional Medicine?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/integrative-and-functional-medicine-in-practice/why-are-so-manyclinicians-choosing-practice-functional-medicine/8424/
More information